Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Allink Biotherapeutics Co., Ltd.

Clinical trials sponsored by Shanghai Allink Biotherapeutics Co., Ltd., explained in plain language.

Trials to join now! 1 Not yet recruiting 2

New hope for advanced cancer: first human trial of ALK201 begins

Disease control Recruiting now

This study tests a new drug, ALK201, for the first time in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 202 adults aged 18 to 75 will take part. The study is currently r…

Phase 1/2 • Sponsor: Shanghai Allink Biotherapeutics Co., Ltd. • Aim: Disease control

Last updated Jun 27, 2026 12:36 UTC